Lineage Cell Therapeutics

IPO

Public · Carlsbad, United States · Founded 1990 · $110.5M raised

Employees
51–200
Founded
1990
Business Model
B2B
Total Funding
$110.5M
Last Round
$50.0M Corporate RoundJan 2022
Rounds
3
Type
Public

About

Lineage Cell Therapeutics is a clinical-stage biotech developing 'off-the-shelf' allogeneic cell therapies using its proprietary AlloSCOPE platform. The company creates specialized human cells through directed differentiation of pluripotent cell lines and transplants them into patients to replace or support cells lost to degenerative disease, aging, or injury. Lead programs include OpRegen for dry AMD and OPC1 for spinal cord injury.

Summary

Lineage Cell Therapeutics is a Biotech company based in Carlsbad, United States, founded in 1990. It has raised $110.5M in total across 3 rounds, most recently a $50.0M Corporate Round round in Jan 2022. Investors include Genentech and Juvenescence.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundJan 2022
$50.0M

Sign up to see all 3 rounds

Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lineage Cell Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/lineage-cell-therapeutics"><img src="https://indexed.vc/api/badge/company/lineage-cell-therapeutics" alt="Lineage Cell Therapeutics on Indexed.vc" width="260" height="76" /></a>